Literature DB >> 10400711

Maturation of the hepatitis A virus capsid protein VP1 is not dependent on processing by the 3Cpro proteinase.

A Martin1, D Bénichou, S F Chao, L M Cohen, S M Lemon.   

Abstract

Most details of the processing of the hepatitis A virus (HAV) polyprotein are known. Unique among members of the family Picornaviridae, the primary cleavage of the HAV polyprotein is mediated by 3Cpro, the only proteinase known to be encoded by the virus, at the 2A/2B junction. All other cleavages of the polyprotein have been considered to be due to 3Cpro, although the precise location and mechanism responsible for the VP1/2A cleavage have been controversial. Here we present data that argue strongly against the involvement of the HAV 3Cpro proteinase in the maturation of VP1 from its VP1-2A precursor. Using a heterologous expression system based on recombinant vaccinia viruses directing the expression of full-length or truncated capsid protein precursors, we show that the C terminus of the mature VP1 capsid protein is located near residue 764 of the polyprotein. However, a proteolytically active HAV 3Cpro that was capable of directing both VP0/VP3 and VP3/VP1 cleavages in vaccinia virus-infected cells failed to process the VP1-2A precursor. Using site-directed mutagenesis of an infectious molecular clone of HAV, we modified potential VP1/2A cleavage sites that fit known 3Cpro recognition criteria and found that a substitution that ablates the presumed 3Cpro dipeptide recognition sequence at Glu764-Ser765 abolished neither infectivity nor normal VP1 maturation. Altered electrophoretic mobility of VP1 from a viable mutant virus with an Arg764 substitution indicated that this residue is present in VP1 and that the VP1/2A cleavage occurs downstream of this residue. These data indicate that maturation of the HAV VP1 capsid protein is not dependent on 3Cpro processing and may thus be uniquely dependent on a cellular proteinase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400711      PMCID: PMC112698     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Mengo virus maturation is accompanied by C-terminal modification of capsid protein VP1.

Authors:  U Boege; D G Scraba
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

3.  Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus.

Authors:  J I Cohen; B Rosenblum; J R Ticehurst; R J Daemer; S M Feinstone; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA.

Authors:  J W Taylor; J Ott; F Eckstein
Journal:  Nucleic Acids Res       Date:  1985-12-20       Impact factor: 16.971

5.  Characterization of hepatitis A virus structural proteins.

Authors:  V Gauss-Müller; F Lottspeich; F Deinhardt
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

6.  Complementation and genetic linkage between vaccinia virus temperature-sensitive mutants.

Authors:  R Drillien; D Spehner; A Kirn
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

7.  Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture.

Authors:  J I Cohen; J R Ticehurst; S M Feinstone; B Rosenblum; R H Purcell
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

8.  Molecular cloning and partial sequencing of hepatitis A viral cDNA.

Authors:  D L Linemeyer; J G Menke; A Martin-Gallardo; J V Hughes; A Young; S W Mitra
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

9.  Proteinase 3C-mediated processing of VP1-2A of two hepatitis A virus strains: in vivo evidence for cleavage at amino acid position 273/274 of VP1.

Authors:  C Probst; M Jecht; V Gauss-Müller
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

10.  Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles.

Authors:  D A Anderson; B C Ross
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

View more
  11 in total

1.  Characterization of recombinant hepatitis A virus genomes containing exogenous sequences at the 2A/2B junction.

Authors:  M R Beard; L Cohen; S M Lemon; A Martin
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Expression of an antigenic adenovirus epitope in a group B coxsackievirus.

Authors:  K Höfling; S Tracy; N Chapman; K S Kim; J Smith Leser
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 3.  Hepatitis A Virus Genome Organization and Replication Strategy.

Authors:  Kevin L McKnight; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2018-12-03       Impact factor: 6.915

4.  Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor.

Authors:  Yan Yang; Yuqiong Liang; Lin Qu; Zeming Chen; Minkyung Yi; Kui Li; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

5.  Replication of subgenomic hepatitis A virus RNAs expressing firefly luciferase is enhanced by mutations associated with adaptation of virus to growth in cultured cells.

Authors:  MinKyung Yi; Stanley M Lemon
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Processing of the VP1/2A junction is not necessary for production of foot-and-mouth disease virus empty capsids and infectious viruses: characterization of "self-tagged" particles.

Authors:  Maria Gullberg; Charlotta Polacek; Anette Bøtner; Graham J Belsham
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

7.  Analysis of deletion mutants indicates that the 2A polypeptide of hepatitis A virus participates in virion morphogenesis.

Authors:  Lisette Cohen; Danièle Bénichou; Annette Martin
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Peek-a-boo: membrane hijacking and the pathogenesis of viral hepatitis.

Authors:  Zongdi Feng; Stanley M Lemon
Journal:  Trends Microbiol       Date:  2013-11-19       Impact factor: 17.079

Review 9.  Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis.

Authors:  Debajit Dey; Manidipa Banerjee
Journal:  J Clin Transl Hepatol       Date:  2016-09-25

10.  Hepatitis A virus (HAV) packaging size limit.

Authors:  Krishnamurthy Konduru; Siham M Nakamura; Gerardo G Kaplan
Journal:  Virol J       Date:  2009-11-18       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.